Source: Acrofan

CohBar: CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)

Read full article »

CohBar's Competitors | CohBar's News | CohBar's Financials

Followers on Owler

4

Annual Revenue

$100K-5.0M

Employees

1-25

Joseph J. Sarret's photo - CEO of CohBar

CEO

Joseph J. Sarret

CEO Approval Rating

- -/100

CohBar engaged in the research and development of mitochondria-based therapeutics.